Cyclosporin A treatment in severe childhood psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 6, 2006, Pages 651-656

  Pereira, T M ^a   Vieira, A P ^a   Fernandes, J C ^a   Sousa Basto, A ^a  

^a HOSPITAL DE BRAGA   (Portugal)

Author keywords

Acitretin; Childhood psoriasis; Cyclosporin A; Retinoids

Indexed keywords

COAL TAR; COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; ETRETIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INFANT; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MICROEMULSION; PRIORITY JOURNAL; PSORIASIS; REMISSION; REVIEW;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; INFANT; MALE; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33745240959     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01562.x     Document Type: Review

References (31)

1. Morris A, Rogers M, Fisher G et al. Childhood psoriasis: A clinical review of 1262 cases. Pediatr Dermatol 2001; 18: 188-198.
2. Farber EM, Nall L. Childhood psoriasis. Cutis 1999; 64: 309-314.
3. Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24: 341-345.
4. Kopp T, Karlhofer F, Szepfalusi Z et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type. Br J Dermatol 2004; 151: 912-916.
5. Rosinska D, Wolsha H, Jablonka S et al. Etretinate in severe psoriasis in children. Pediatr Dermatol 1988; 5: 266-272.
6. Shelnitz LS, Esterly NB, Honig PJ. Etretinate therapy for generalized pustular psoriasis in children. Arch Dermatol 1987; 123: 230-233.
7. Lacour M, Mehta-Nikhar B, Atherton DJ et al. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br J Dermatol 1996; 134: 1023-1029.
8. Dogra S, Handa S, Kanwar AJ. Methotrexate in severe childhood psoriasis. Pediatr Dermatol 2004; 21: 283-284.
9. Kumar B, Dhar S, Handa S et al. Methotrexate in childhood psoriasis. Pediatr Dermatol 1994; 11: 271-273.
10. Lebwohl M, Ellis C, Gottlieb A et al. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 1998; 39: 464-475.
11. Mahé E, Bodemer C, Pruszkowski A et al. Cyclosporine in childhood psoriasis. Arch Dermatol 2001; 137: 1532-1533.
12. Perret CM, Ilchyshyn A, Berth Jones J. Cyclosporine in childhood psoriasis. J Dermatol Treat 2003; 14: 113-118.
13. Kilic SS, Hacimustafaoglu M, Celebi S et al. Low dose cyclosporine: A treatment in generalized pustular psoriasis. Pediatric Dermatol 1997; 32: 481-495.
14. Alli N, Gungor E, Karakayalli G et al. The use of cyclosporine in a child with generalized pustular psoriasis. Br J Dermatol 1998; 139: 754-755.
15. Wollina U, Funfstuck V. Juvenile generalized circinate pustular psoriasis treated with oral cyclosporine A. Eur J Dermatol 2001; 11: 117-119.
16. Maldonado R, Tamayo L. Retinoids in disorders of keratinisation: Their use in children. Dermatologica 1987; 175: 125-132.
17. Mahrle G, Schulze HJ, Farber L et al. Low-dose short-time cyclosporine versus etretinate in psoriasis: Improvement of skin, nail and joint involvement. J Am Acad Dermatol 1995; 32: 78-88.
18. Berth-Jones J, Finlay AY, Zaki I et al. Cyclosporine in severe childhood atopic dermatitis: A multicenter study. J Am Acad Dermatol 1996; 34: 1016-1021.
19. Harper JI, Ahmed I, Barclay G et al. Cyclosporin for severe childhood atopic dermatitis: Short course versus continuous therapy. Br J Dermatol 2000; 142: 52-58.
20. Harper JI, Berth-Jones J, Camp RDR et al. Cyclosporin for atopic dermatitis in children. Dermatology 2001; 203: 3-6.
21. Robitaille P, Chartrand S, Stanley C et al. Long-term assessment of renal function under cyclosporine in pediatric heart transplant recipients. J Heart Lung Transplant 1991; 10: 460-463.
22. Heckmatt J, Hasson N, Saunders C et al. Cyclosporin in juvenile dermatomyositis. Lancet 1989; 1: 1063-1066.
23. Bougners PF, Carel JC. Castano L et al. Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 1988; 318:663 -670.
24. Cooney GF, Habucky K, Hoppu K. Cyclosporine pharmacokinetics in pediatric transplant recipients. Clin Pharmacokinet 1997; 32: 481-495.
25. Feutren G, Mihatsche MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-1660.
26. Ryffel B, Mihatsch MJ, Fisher GL. Immunosuppression and cancer: The cyclosporine case. Drug Chem Toxicol 1992; 15: 95-115.
27. Ellis CN. Safety issues with cyclosporine. Int J Dermatol 1997; 36: 7-10.
28. Griffiths C, Powles A, Baker B et al. Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis. Transplant Proc 1988; 20: 50-52.
29. Gottlieb SL, Heftler NS, Gilleaudeau P. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: clinical and pathological study. J Am Acad Dermatol 1995; 33: 637-645.
30. Kokelj F, Torsello P, Plozzer C. Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 1998; 10: 143-146.
31. Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998; 39: S62-S66.